Cargando…
Efficacy of AAV9-mediated SGPL1 gene transfer in a mouse model of S1P lyase insufficiency syndrome
Sphingosine-1-phosphate lyase insufficiency syndrome (SPLIS) is a rare metabolic disorder caused by inactivating mutations in sphingosine-1-phosphate lyase 1 (SGPL1), which is required for the final step of sphingolipid metabolism. SPLIS features include steroid-resistant nephrotic syndrome and impa...
Autores principales: | Zhao, Piming, Tassew, Gizachew B., Lee, Joanna Y., Oskouian, Babak, Muñoz, Denise P., Hodgin, Jeffrey B., Watson, Gordon L., Tang, Felicia, Wang, Jen-Yeu, Luo, Jinghui, Yang, Yingbao, King, Sarah, Krauss, Ronald M., Keller, Nancy, Saba, Julie D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119223/ https://www.ncbi.nlm.nih.gov/pubmed/33755599 http://dx.doi.org/10.1172/jci.insight.145936 |
Ejemplares similares
-
AAV-SPL 2.0, a Modified Adeno-Associated Virus Gene Therapy Agent for the Treatment of Sphingosine Phosphate Lyase Insufficiency Syndrome
por: Khan, Ranjha, et al.
Publicado: (2023) -
SGPL1 (sphingosine phosphate lyase 1) modulates neuronal autophagy via phosphatidylethanolamine production
por: Mitroi, Daniel N., et al.
Publicado: (2017) -
Sphingosine-1-phosphate lyase (SGPL1) deficiency is associated with mitochondrial dysfunction
por: Maharaj, A., et al.
Publicado: (2020) -
Nephrotic syndrome and adrenal insufficiency caused by a variant in SGPL1
por: Linhares, Natália Duarte, et al.
Publicado: (2018) -
Neurological Consequences of Sphingosine Phosphate Lyase Insufficiency
por: Atreya, Krishan B., et al.
Publicado: (2022)